Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Dri Healthcare Trust
T.DHT.UN
Alternate Symbol(s):
DHTRF
Healthcare
Biotechnology
DRI Healthcare Trust is a Canada-based company engaged in global pharmaceutical royalty monetization. The Company is involved in pharmaceutical royalty monetization and provides capital to inventors, academic institutions and biopharma companies. It acquires more than 25 royalties on 20-plus drugs, including Eylea, Orserdu, Omidria, Spinraza, Stelara, Vonjo, Zejula and Zytiga. Its portfolio...
includes Empaveli/Syfovre, Eylea I, Eylea II, Ilaris, Natpara, Omidria, Oracea, Orserdu I, Orserdu II, Rydapt, Simponi, Spinraza, Stelara, Vonjo I, Vonjo II, Xenpozyme, Xolair, Zejula, Zytiga, sebetralstat, and others. Its therapeutic areas include hematology, ophthalmology, influenza, endocrinology, dermatology, oncology, neurology, immunology, lysosomal storage disorder, hereditary angioedema, and others. The Company is managed by DRI Capital Inc. Its products are marketed by pharmaceutical companies, including Regeneron, Bayer, Santen; AstraZeneca; Takeda; Galderma Laboratories; and others.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:DHT.UN)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(17)
•••
HermannHaller
X
Comment by
HermannHaller
on May 13, 2025 9:48am
RE:RE:RBC
Yes, great call! Big pipeline, portfolio 'insulated' from potential tariffs, CEO taking 95% of comp in shares. Very positive message here. Also, the CFO clarified that there were $3.9 million
...more
(80)
•••
SONOFFERGUS
X
Comment by
SONOFFERGUS
on May 13, 2025 9:27am
RE:RBC
Plus NCIB is back. On earnings call, CEO said they will continue to weigh IRRs of new investment vs. buyback but that it's no contest at current unit price
(6073)
•••
retiredcf
X
Post by
retiredcf
on May 13, 2025 8:18am
RBC
May 12, 2025 DRI Healthcare Trust Q1/25 - Results mixed; Announces internalization of the manager at ~4x trailing fees - positive news TSX: DHT-U | CAD
...more
(0)
•••
PressRelease
X
Post by
PressRelease
on May 12, 2025 5:01pm
New Press Release - DRI Healthcare Trust Reports First Quarter 2025 Results and Announces Internalization of Manager
Definitive agreements for internalization transaction entered into with manager, estimated to deliver $200 million in cumulative savings over 10 years1Portfolio assets generate second highest cash receipts and Adjusted EBITDA since IPONormal course issuer bid reactivated with ability to purchase...
read article.
(17)
•••
HermannHaller
X
Comment by
HermannHaller
on May 08, 2025 11:10am
RE:RE:RE:RE:RE:RE:RE:T3 Error Update
Stock is recovering nicely, maybe that was the smell of money you were smelling. Haha
•••
Jonathon Brown
X
Post by
Jonathon Brown
on May 08, 2025 9:17am
Buzz on the Bullboards: From oil fields to labs, TSX Stories making waves
Several TSX and TSX Venture-listed companies made significant announcements that could shape their near-term trajectories.
read article.
(12)
•••
raybay_98
X
Comment by
raybay_98
on Apr 25, 2025 12:41pm
RE:RE:RE:RE:RE:RE:T3 Error Update
As the old saying goes, " One Shoe Dropped, When Will The Second Shoe Drop?", and there-in lies the problem imo. It appears this carcas can only attract flies, not looking good or smelling
...more
(17)
•••
HermannHaller
X
Post by
HermannHaller
on Apr 24, 2025 9:26am
Analyst note
NBF reiterated $18 target today. Notes that the value of the current portfolio is C$13.50/unit, plus growth. Comp table shows RPRX at 9.8x EBITDA, vs DHT at 4.7x. RPX at 1.4x book value, DHT at 0.8x.
...more
(80)
•••
SONOFFERGUS
X
Comment by
SONOFFERGUS
on Apr 22, 2025 7:22pm
RE:RE:RE:RE:RE:RE:T3 Error Update
I'll add a caveat tho. DHT may be inside on the KALV news so may have to come behind. Better tho, do it now on $10.85! I dunno how it can get cheaper (I have said 1,000 times lol).
(80)
•••
SONOFFERGUS
X
Comment by
SONOFFERGUS
on Apr 22, 2025 4:49pm
RE:RE:RE:RE:RE:T3 Error Update
Makes sense to me! That the units are trading below the $11 secondary offering in September/23 is absolutely insane. Lots of good things (and one very bad thing, since resolved) have happened
...more
(17)
•••
HermannHaller
X
Comment by
HermannHaller
on Apr 22, 2025 3:42pm
RE:RE:RE:RE:T3 Error Update
As you noted, mgmt get more shares in reorg if share price is low. So they have little incentive to boost the price right now (perhaps why they decided to hold on the NCIB?). Not fair to other
...more
(80)
•••
SONOFFERGUS
X
Comment by
SONOFFERGUS
on Apr 22, 2025 3:35pm
RE:RE:RE:T3 Error Update
Hey. I'm glad that it's only a few dollars given how terribly DHT has performed since the fraud. I continue to think that (1) Kalvista's stock price and words from its CEO are telling us
...more
(0)
•••
PressRelease
X
Post by
PressRelease
on Apr 22, 2025 3:05pm
New Press Release - DRI Healthcare Trust to Host First Quarter 2025 Earnings Call and Webcast on May 13, 2025
TORONTO, April 22, 2025 /CNW/ - DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (the "Trust"), a global leader in providing financing to advance innovation in the life sciences industry, announces that it will hold a conference call to discuss its first quarter 2025 financial results on Tuesday...
read article.
(40)
•••
junglejames
X
Comment by
junglejames
on Apr 22, 2025 8:49am
RE:RE:T3 Error Update
SonofFergus: Thanks for your insights! I hold most of my DHT in a TFSA to avoid T3's but I picked up units some in my "fun account" and what a pain. However it has been
...more
(80)
•••
SONOFFERGUS
X
Comment by
SONOFFERGUS
on Apr 19, 2025 1:00pm
RE:T3 Error Update
Hey junglejames. Annoying. I bought DHT for the first time in 2024 so spent a minute reconciling the T3 I received from TD Direct. The T3 income for cash distributions ties in to the cash
...more
(80)
•••
SONOFFERGUS
X
Post by
SONOFFERGUS
on Apr 16, 2025 5:19pm
Price Action
FWIW, DHT traded up smartly today while every other pharma name was getting smashed. Dunno if that means anything, but this stock hasn't shown any fight in months. Good luck to any longs left!
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Largest integrated facility services provider in Canada releases financial results for Q1, 2025
How Web3 Will Fundamentally Reshape Finance
This company is set to benefit from a change in Ontario legislation